S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NanobiotixInventivaBiotest AktiengesellschaftAptose BiosciencesErgomed
SymbolNASDAQ:NBTXNYSE:IVAETR:BIOTSE:APSLON:ERGO
Price Information
Current Price$16.62$15.00€30.40C$5.07GBX 1,250
52 Week RangeBuyBuyN/ABuyN/A
MarketRank™
Overall Score1.11.70.51.30.6
Analysis Score0.03.50.03.50.0
Community Score5.05.02.32.83.1
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.60.00.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyN/A
Consensus Price TargetN/A$27.33N/AC$12.00N/A
% Upside from Price TargetN/A82.22% upsideN/A136.69% upsideN/A
Trade Information
Market Cap$554.11 million$575.90 million$601.49 millionC$450.53 million£609 million
BetaN/AN/AN/AN/AN/A
Average Volume38,94141,3211,92742,957120,053
Sales & Book Value
Annual RevenueN/AN/A$465.80 millionN/A£73.46 million
Price / SalesN/AN/A1.29N/A8.29
CashflowN/AN/A€1.80 per shareC$1.39 per shareGBX 60.93 per share
Price / CashN/AN/A16.873.6420.52
Book ValueN/AN/A€11.47 per shareC$1.45 per shareGBX 90.60 per share
Price / BookN/AN/A2.65N/A0.14
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/A(€0.80)C($0.65)GBX 12.50
Trailing P/E Ratio0.000.00N/AN/A100.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/A€0.04N/AN/A
Dividend YieldN/AN/A0.13%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A105.45%0.93%48.12%
Current RatioN/AN/A5.25%24.60%1.44%
Quick RatioN/AN/A2.18%24.38%1.40%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees98861,83731850
Shares Outstanding33.34 million38.39 million19.79 million88.86 million48.72 million
Next Earnings DateN/AN/A3/31/2021 (Estimated)3/9/2021 (Estimated)3/22/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.